Correction: Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines

Cureus. 2021 Feb 12;13(2):c41. doi: 10.7759/cureus.c41.

Authors

Mariah Siddiqui^{1

2}, Parth V Shah³, Prachi Balani⁴, Angel R Lopez⁵, Chelsea Mae N Nobleza², Safeera Khan⁴

Affiliations

¹ Neurology, St. George's University, True Blue, GRD.
² Neurology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
³ Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
⁴ Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
⁵ Psychiatry, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Abstract

[This corrects the article DOI: 10.7759/cureus.13002.].

Copyright © 2021, Siddiqui et al.

Publication types

Published Erratum